ABVX Spotlights Seven Obefazimod Abstracts at UEG Week 2026, Featuring Phase 3 Maintenance and Long-Term Phase 2 Follow-Up
Market Chameleon (Thu, 1-Oct 7:10 AM)
Abivax Gains FDA Alignment on NDA Path for Obefazimod—Paving Way for 2026 Filing in Ulcerative Colitis
Market Chameleon (Fri, 31-Jul 7:08 AM)
